Adaptive Biotechnologies Corp (ADPT) CEO Chad Robins on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/13/19
Adaptive Biotechnologies beats estimates with Q3 revenue of $26.1M as shares rise 6%GeekWire • 11/12/19
Adaptive and Illumina to make immune sequencing kits for labs, streamlining the detection of diseaseGeekWire • 09/24/19
Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ DxGlobeNewsWire • 09/24/19
Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ® as Preferred MRD Test for Drug Development Across Amgen’s Hematology FranchiseGlobeNewsWire • 09/17/19
Adaptive Biotechnologies Corp (ADPT) CEO Chad Robins on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/14/19
Adaptive Biotechnologies shares drop as loss widens in first quarterly earnings since IPOGeekWire • 08/13/19
Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public companyGeekWire • 06/27/19
Adaptive Biotech and BridgeBio shares rocket higher on their first day of tradeMarket Watch • 06/27/19